Good morning :)
Switch to
Place Order

Jubilant Pharmova Ltd

JUBLPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,075 cr, stock is ranked 479
Moderate RiskStock is 2.13x as volatile as Nifty
380.900.21% (-0.80)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,075 cr, stock is ranked 479
Moderate RiskStock is 2.13x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
14.681.141.31%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.924.360.88%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jubilant Pharmova Ltd, formerly Jubilant Life Sciences Ltd, is an India-based pharmaceuticals company. The Company's segments include Pharmaceuticals, Contract Research and Development Services, and Proprietary Novel Drugs. The Pharmaceuticals segment operates through Jubilant Pharma Limited, which is engaged in manufacturing and supply of Radiopharmaceuticals in the United States, Allergy Therapy Products, Contract Manufacturing of Sterile Injectables and Non-sterile products, Active Pharmaceutical Ingredients and Solid Dosage Formulations. The Contract Research and Development Services segment operates through Jubilant Biosys Limited, which provides research to global pharmaceutical innovators through two research centers in Bengaluru and Noida in India. Its Proprietary Novel Drugs business through Jubilant Therapeutics Inc., is a patient-centric biopharmaceutical, developing therapies in the area of oncology and auto-immune disorders.

Brands

Jubilant Life Sciences

Pharmaceutical company

Brands

Jubilant Life Sciences

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+9.15+6.23+6.39+6.14+0.57+0.90+0.84+0.41
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General updates 
Announced OnNov 17, 2022

Jubilant Pharmova Limited has informed the Exchange about Grant of Stock Options | Download

Jubilant Pharmova Limited has informed the Exchange about Grant of Stock Options | Download

Postal Ballot 
Announced OnNov 14, 2022

Jubilant Pharmova Limited has informed the Exchange about Voting results and Scrutinizer report of Postal Ballot | Download

Jubilant Pharmova Limited has informed the Exchange about Voting results and Scrutinizer report of Postal Ballot | Download

Cash Dividend 
Ex. DateAug 11, 2022

Final • Div/Share: ₹ 5

See all events